We are live on
!
Find out more
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
149 hedge funds and large institutions have $291M invested in Synergy Pharmaceuticals, Inc Common Stock in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 52 increasing their positions, 40 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
35% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 23
30% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 40
4% more funds holding
Funds holding: 143 → 149 (+6)
33% less capital invested
Capital invested by funds: $436M → $291M (-$144M)
51% less call options, than puts
Call options by funds: $4.07M | Put options by funds: $8.28M
Holders
149
Holders Change
+6
Holders Change %
+4.2%
% of All Funds
3.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
52
Reduced
40
Closed
23
Calls
$4.07M
Puts
$8.28M
Net Calls
-$4.2M
Net Calls Change
+$1.47M
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$29.3M |
| 2 |
State Street
Boston,
Massachusetts
|
+$18.1M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$17.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5M |
| 5 |
BlackRock
New York
|
+$4.38M |
Top Sellers
| 1 |
PC
Paulson & Co
New York
|
-$49.9M |
| 2 |
O
OrbiMed
New York
|
-$39.5M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$14.6M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$9.49M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$5.86M |
